The Fifth Circuit today gave the FTC (and U.S. consumers) a huge win today in finding that Endo and Impax entered into a pay-for-delay settlement that delayed the entry of opioid Opana ER.
The opinion reached the result suggested by Prof. Michael Carrier in his brief on behalf of 82 professors.
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3504773
Link to opinion…
FTC v. Impax ruling